Top 3 generic pharmaceutical companies based on U.S. revenue 2012
This statistic illustrates the top three generic pharmaceutical companies in 2012, based on U.S. revenue and operating income. That year, Sandoz is expected to generate just under 3.3 billion U.S. dollars in revenue in the United States.